Trial Profile

Optimisation of insulin treatment of type 2 diabetes mellitus by Telecare assistance for self monitoring of blood glucose (SMBG).

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary)
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms ELEONOR
Sponsors Sanofi

Most Recent Events

05 Jun 2009 Quality-of-life and treatment satisfaction results presented at ADA 2009.
12 May 2009 Actual patient number (352) added as reported by ClinicalTrials.gov.
11 Sep 2008 Interim results published in the proceedings of the 44th Annual Meeting of the European Association for the Study of Diabetes.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com